Skip to content

Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ureteroscope

Surgical Outcomes and Costs in Using the Shenzhen HugeMed 6.3 French Flexible Ureteroscope

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07296835
Enrollment
75
Registered
2025-12-22
Start date
2026-05-01
Completion date
2028-11-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stones

Keywords

hugemed, coast saving, ureteroscopy

Brief summary

Comprehensive comparative investigations between HugeMed HU30M 6.3 Fr f-URS and traditional approach f-URS devices in RIRS are lacking in an American population. The investigators aim to compare the outcomes of using the 6.3 Fr f-URS versus traditional approach (other f-URS present in our institution) to treat patients with stone burden ≤ 2.5 cm. The findings of this study will expand on the potential advantages and drawbacks of HU30M in enhancing surgical outcomes and patient safety in RIRS procedures. We hypothesize that the use of the HU30M will result in increased cost savings while providing similar stone free rates when compared to traditionally used f-URS devices.

Interventions

DEVICEUreteroscopy using the 6.3 Fr f-URS hugemed

All patients will be counseled on standard treatment options. Treatment options and subsequent care will not deviate from routine care. If they do not enroll in the study, the HU30M may still be used during routine surgery and care. The only intervention specific to the research will involve the use of patient information in describing the results. Participants will undergo RIRS in standard fashion, without deviation from the standard of care. Patients will be brought to the operating room, positioned, and placed under general anesthesia. RIRS will be performed using HU30M 6.3 Fr f-URS. Laser platform (ex: HoYAG or TFL) as well as laser settings will be at the treating investigator's discretion and may be changed during the procedure at their discretion as well, all per standard of care. The initial laser settings and changes that occurred to the settings after the first minute of the case will be recorded.

DEVICEHugemed 6.3 Fr f-URS

Retrograde intrarenal surgery will be performed using HU30M 6.3 Fr f-URS.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER
HugeMed
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study employs a hybrid design: a prospective single-arm cohort of patients undergoing RIRS, with outcomes measured at predefined intervals. To provide comparative context, a retrospective control cohort will be identified from KUMC's electronic medical records of patients who also underwent RIRS by SOC with traditional f-URS scope, matched 2:1 based on key baseline characteristics (e.g., age, sex, stone size, etc.). This will allow for retrospective comparison of outcomes between the intervention group and standard management.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males or females ≥ 18 years of age * Patients with ureteral or kidney stones undergoing primary flexible ureteroscopy for retrograde intrarenal surgery * Total stone burden ≤ 2.5 cm

Exclusion criteria

* Undergoing bilateral stone treatment during the same procedure * Patients with known genitourinary anatomical abnormalities that would complicate the procedure as determined by the treating investigator * Uncorrected coagulopathy * Patients with urinary diversions * Chronic external urinary catheters * Women who are pregnant * Immunosuppressed patients * Non-elective procedures * Participants must not be involved in any other clinical research studies during the duration of this trial. Exceptions may be made if the investigator determines, on a case-by-case basis, that participation in another study will not adversely affect the outcomes or integrity of this trial

Design outcomes

Primary

MeasureTime frameDescription
To evaluate and compare outcomes and costs associated with hugeMed 6.3 Fr flexible URS versus traditional approach in RIRS36 monthsStone free rate, defined as the absence of residual stone fragments \> 2 mm, as determined by noncontrast CT scan performed

Countries

United States

Contacts

CONTACTWilson R. Molina, MD
wmolina@kumc.edu913-588-8721
CONTACTJane Research Project Manager
jledesma2@kumc.edu913-588-8721
PRINCIPAL_INVESTIGATORWilson R. Molina, MD

University of Kansas Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026